Home > News > Coalition aims to develop 'smart' nanoscience drugs
October 30th, 2008
Coalition aims to develop 'smart' nanoscience drugs
A coalition of Irish universities and colleges came together today for an ambitious plan to develop "smart" drugs to fight cancer and other life-threatening diseases.
Ten of the country's top third-level institutions will share expertise and technology in the emerging nanoscience field under the €32 million project.
The Inspire partnership, unveiled by Jimmy Devins, Minister of State for Science and Innovation, will be headed up by Trinity College, which opened the country's first nanoscience institute earlier this year.
The Higher Education Authority (HEA) allocated €31.6 million to Inspire, the largest funding allocation awarded to a consortium under the Government's Programme for Research in Third Level Institutions.
The scheme will allow around 500 researchers access to cutting-edge equipment including clean room facilities seen only in world-leading computer chip manufacturing companies.
News and information
Light pulses control graphene's electrical behavior: Finding could allow ultrafast switching of conduction, and possibly lead to new broadband light sensors August 1st, 2014
President Obama Meets U.S. Laureates of 2014 Kavli Prizes August 1st, 2014
Stanford researchers seek 'Holy Grail' in battery design: Pure lithium anode closer to reality with development of protective layer of interconnected carbon domes August 1st, 2014
Air Force’s 30-year plan seeks 'strategic agility' August 1st, 2014
University of Manchester selects Anasys AFM-IR for coatings and corrosion research July 30th, 2014
Haydale Announces Collaboration Agreement with Swansea University’s Welsh Centre for Printing and Coatings (WCPC) July 12th, 2014
STFC takes delivery of the 100th Hitachi Tabletop SEM in the UK July 3rd, 2014
Innovation Management and the Emergence of the Nanobiotechnology Industry July 1st, 2014
Taking the guesswork out of cancer therapy: New molecular test kit predicts patient’s survival and drug response August 1st, 2014
Arrowhead to Report Fiscal 2014 Third Quarter Financial Results- Conference Call Scheduled for Tuesday, August 12, 2014 - July 31st, 2014
New imaging agent provides better picture of the gut July 30th, 2014
Zenosense, Inc. July 29th, 2014
Nature inspires a greener way to make colorful plastics July 30th, 2014
SouthWest NanoTechnologies Names NanoSperse as A SWeNT Certified Compounder July 29th, 2014
ACS Biomaterials Science & Engineering™: Brand-new journal names editor July 29th, 2014
A*STAR and industry form S$200M semiconductor R&D July 25th, 2014